News

The European Commission has published a new version of the Questions & Answers (Q&A) document on “Safety Features for Medicinal Products for Human Use (V.20)”.

EMVO Community Newsletter June 2022 you will find an overview of the latest developments and activities in our community, starting with a deep dive into the end of the stabilisation period in Ireland and finishing off with a summary of the best practices on Product Code Unknown (A1).

On May 31, a new Core 1.10 release was deployed into the production environment of the Latvian Medicines Verification System (LZVS).

The unique identifier on that pack should not be decommissioned in the verification system by the end-users – pharmacies, wholesalers, healthcare institutions – if the specific pack has already expired.

EMVO repeatedly reminds to all medicines manufacturers, On-boarding partners (OBP) about the quality of data that uploaded to the EU HUB and further transmitted to the national medicines verification organisations.